Key result
Combining surgical arterial grafting with percutaneous revascularization using drug-eluting stents may provide better long-term outcomes than the continued use of saphenous vein grafts.
Answers are grounded in this paper and cite their sources.
The authors propose a moratorium on saphenous vein grafts in favor of combining surgical arterial grafting with percutaneous revascularization using drug-eluting stents for complex coronary artery disease.
Atherosclerosis develops and rapidly progresses in saphenous veins grafts after coronary bypass surgery. In contrast to native coronary artery, percutaneous revascularization does not impede the progression of saphenous vein atherosclerosis and saphenous vein graft failure commonly ensues. The protracted patency of arterial grafts is likely to account for most of the long-term superiority of coronary artery bypass surgery over percutaneous revascularization in patients with complex coronary artery disease. Long-lasting, complete coronary revascularization may be best achieved by combining surgical arterial grafting of diseased coronary arteries to percutaneous revascularization with drug-eluting stents than by the continued use of saphenous vein grafts.
No takes yet. Share an insight, caveat, or question.
Motwani et al. (2020) conducted an editorial in Complex coronary artery disease. Saphenous vein grafts vs. Arterial grafting and percutaneous revascularization was evaluated. Combining surgical arterial grafting with percutaneous revascularization using drug-eluting stents may provide better long-term outcomes than the continued use of saphenous vein grafts.
Synapse has enriched 10 related papers. Consider them for comparative context: